Investors & Media
Investors & Media
- Overview
- News Releases
- Events & Presentations
- Stock Information
- Corporate Governance
- Financial Information
- Investor Resources
Stockholder Tools
Events & Presentations
Events & Presentations
Corporate Presentation
April 16, 2024
Corporate Presentation 6.3 MB
Upcoming Events
April 29, 2024 at 11:00 AM EDT
May 15, 2024 at 10:40 AM PDT
June 12, 2024 at 2:40 PM EDT
Past Events
November 30, 2023 at 9:00 AM EST
November 28, 2023 at 10:25 AM EST
October 02, 2023 at 2:00 PM EDT
June 27, 2023 at 8:00 AM EDT
May 17, 2023 at 10:00 AM EDT
May 10, 2023 at 2:35 PM PDT
April 24, 2023 at 2:30 PM EDT
December 13, 2022 at 8:00 AM EST
December 07, 2022 at 4:05 PM EST
December 01, 2022 at 9:15 AM EST
November 29, 2022 at 8:30 AM EST
October 01, 2022 at 9:55 AM EDT
Retina Subspecialty Day 2 (for registered attendees)
Section X: Late Breaking Developments, Part II
Oral Presentation
Abstract Title: Ph1/2 AAV5-RPGR (Botaretigene Sparoparvovec) Gene Therapy Trial in RPGR-associated X-linked Retinitis Pigmentosa (XLRP)
Presenter: Dr. Michel Michaelides, Professor of Ophthalmology, UCL Institute of Ophthalmology in Dept. of Genetics
September 28, 2022
September 28, 2022
This gene therapy company is testing new tech to 'switch off' diabetes and obesity with a pill
September 16, 2022
Press Release 108.9 KB
September 14, 2022 at 3:30 PM EDT
August 14, 2022
A cure for blindness: The London-based company turning back the clock on serious diseases – MeiraGTx
August 04, 2022
June 28, 2022 at 8:00 AM EDT
View Presentation 510.8 KB
May 18, 2022 at 3:35 PM EDT
April 07, 2022
December 15, 2021 at 10:00 AM EST
View Presentation 3.4 MB
December 07, 2021 at 8:00 AM EST
View Presentation 1.6 MB
December 13, 2019 at 9:00 AM EST
View Presentation 156.6 MB
October 12, 2019 at 5:30 PM PDT
View Presentation 7.9 MB
Investors & Media
- Overview
- News Releases
- Events & Presentations
- Stock Information
- Corporate Governance
- Financial Information
- Investor Resources